Loading clinical trials...
Loading clinical trials...
Isoflurane might be used as anticonvulsive therapy in refractory status epilepticus. The aim of the study is to assess the efficiency of Isoflurane in this indication.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hopital of Melun
NCT07496749 · Super-refractory Status Epilepticus
NCT06344338 · Refractory Status Epilepticus
NCT07383779 · Convulsive Refractory Status Epilepticus, Status Epilepticus
NCT07281027 · New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus, and more
NCT05684978 · Refractory Status Epilepticus
Ch Bethune Beuvry
Beuvry
CHU Brest
Brest
GH Sud Ile de France, Hôpital de Melun-Sénart
Melun
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions